Organic Bioelectronics for In Vitro Systems.

Area of Science:

• Bioelectronics
• Materials Science
• Biomedical Engineering

Background:

• Bioelectronics significantly improve clinical diagnostics and precision medicine.
• The integration of bioelectronics with microfluidics and advanced in vitro models offers a path to reduce animal testing in drug discovery and toxicology.
• Organic electronic materials, especially conjugated polymers, are well-suited for bioelectronic applications due to their biomimetic properties and processing versatility.

Purpose of the Study:

• To review advances in conjugated polymers for in vitro bioelectronic interfacing.
• To highlight the development of next-generation in vitro systems using conjugated polymers.
• To discuss the potential and challenges of conjugated polymers for clinical translation of in vitro systems.

Main Methods:

• Review of current literature on conjugated polymers in bioelectronics.
• Showcasing in vitro interfacing across various biological models, from cellular components to 3D cultures.
• Analysis of the state-of-the-art, possibilities, and challenges.

Main Results:

• Conjugated polymers demonstrate significant potential for creating sophisticated in vitro bioelectronic systems.
• Interfacing capabilities span multiple length scales and biological complexities.
• Progress is being made in developing label-free monitoring and precise biological control.

Conclusions:

• Conjugated polymers are key to advancing in vitro systems for drug discovery and toxicology.
• Further development is needed for seamless clinical translation of these technologies.
• Bioelectronics offer a promising future for reducing reliance on animal studies.